Kiniksa Pharmaceuticals
KNSA
#4666
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
46.68%
Change (1 year)
Categories
Earnings for Kiniksa Pharmaceuticals (KNSA)
Earnings in 2023 (TTM): -$16.66 M
According to Kiniksa Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$16.66 M. In 2022 the company made an earning of $11.02 M an increase over its 2021 earnings that were of -$0.16 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Kiniksa Pharmaceuticals from 2017 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$16.66 M | -251.02% |
| 2022 | $11.02 M | -107.04% |
| 2021 | -$0.16 B | 0.2% |
| 2020 | -$0.16 B | -4.69% |
| 2019 | -$0.17 B | 58.46% |
| 2018 | -$0.11 B | 59.46% |
| 2017 | -$64.88 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 565.27% | 🇺🇸 USA |